ACPU
PRVL

Arrowgrass Capital Partners (US)’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-50,000
Closed -$660K – 222
2019
Q2 		$660K Buy
+50,000
New +$660K 0.02% 206